QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
Free Trial

Larimar Therapeutics (LRMR) Earnings Date, Estimates & Call Transcripts

→ 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad)
Free LRMR Stock Alerts
$6.56
+0.18 (+2.82%)
(As of 02:46 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Mar. 14)
-$0.30 Missed By -$0.05
Consensus EPS
(Mar. 14)
-$0.25
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

LRMR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LRMR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Larimar Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.30)($0.25)($0.28)
Q2 20242($0.38)($0.30)($0.34)
Q3 20242($0.47)($0.35)($0.41)
Q4 20242($0.40)($0.39)($0.40)
FY 20248($1.55)($1.29)($1.42)
Q1 20252($0.47)($0.22)($0.35)
Q2 20251($0.50)($0.50)($0.50)
Q3 20251($0.64)($0.64)($0.64)
Q4 20251($0.74)($0.74)($0.74)
FY 20255($2.35)($2.10)($2.23)

LRMR Earnings Date and Information

Larimar Therapeutics last posted its quarterly earnings results on March 14th, 2024. The reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.05. Larimar Therapeutics has generated ($0.85) earnings per share over the last year (($0.85) diluted earnings per share). Earnings for Larimar Therapeutics are expected to decrease in the coming year, from ($1.24) to ($2.13) per share. Larimar Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Larimar Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)		------- 
3/14/2024Q4 2023($0.25)($0.30)($0.05)($0.30)--
11/14/2023Q3 2023($0.23)($0.21)+$0.02($0.21)--
8/10/2023Q2 2023($0.21)($0.19)+$0.02($0.19)--
5/15/2023Q1 2023($0.25)($0.15)+$0.10($0.15)--
3/14/2023Q4 2022($0.78)($0.21)+$0.57($0.21)--
11/10/2022Q3 2022($0.50)($0.37)+$0.13($0.37)--
8/11/2022Q2 2022($0.62)($0.47)+$0.15($0.47)--
5/12/2022Q1 2022($0.62)($0.49)+$0.13($0.49)--
3/25/2022Q4 2021-($0.50)($0.50)($0.50)--
11/12/2021Q3 2021($0.64)($0.92)($0.28)($0.92)--
8/12/2021Q2 2021($0.75)($0.79)($0.04)($0.79)--
5/10/2021Q1 2021($0.87)($0.76)+$0.11($0.76)--

Larimar Therapeutics Earnings - Frequently Asked Questions

When is Larimar Therapeutics's earnings date?

Larimar Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on LRMR's earnings history.

Did Larimar Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Larimar Therapeutics (NASDAQ:LRMR) missed the analysts' consensus estimate of ($0.25) by $0.05 with a reported earnings per share (EPS) of ($0.30). Learn more on analysts' earnings estimate vs. LRMR's actual earnings.

How much profit does Larimar Therapeutics generate each year?

Larimar Therapeutics (NASDAQ:LRMR) has a recorded net income of -$36.95 million. LRMR has generated -$0.85 earnings per share over the last four quarters.

What is Larimar Therapeutics's EPS forecast for next year?

Larimar Therapeutics's earnings are expected to decrease from ($1.24) per share to ($2.13) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:LRMR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press